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Abstract. 
 
b
 
1A integrin subunits with point mutations 
of the cytoplasmic domain were expressed in fibro-
blasts derived from 
 
b
 
1-null stem cells. 
 
b
 
1A in which 
one or both of the tyrosines of the two NPXY motifs 
(Y783, Y795) were changed to phenylalanines formed 
active 
 
a
 
5
 
b
 
1 and 
 
a
 
6
 
b
 
1 integrins that mediated cell adhe-
sion and supported assembly of fibronectin. Mutation 
of the proline in either motif (P781, P793) to an alanine 
or of a threonine in the inter-motif sequence (T788) to 
a proline resulted in poorly expressed, inactive 
 
b
 
1A. 
Y783,795F cells developed numerous fine focal con-
tacts and exhibited motility on a surface. When com-
pared with cells expressing wild-type 
 
b
 
1A or 
 
b
 
1A with 
the D759A activating mutation of a conserved mem-
brane–proximal aspartate, Y783,795F cells had im-
paired ability to transverse filters in chemotaxis assays. 
Analysis of cells expressing 
 
b
 
1A with single Tyr to Phe 
substitutions indicated that both Y783 and Y795 are 
important for directed migration. Actin-containing mi-
crofilaments of Y783,795F cells were shorter and more 
peripheral than microfilaments of cells expressing wild-
type 
 
b
 
1A. These results indicate that change of the 
phenol side chains in the NPXY motifs to phenyl 
groups (which cannot be phosphorylated) has major ef-
fects on the organization of focal contacts and cytoskel-
eton and on directed cell motility.
 
I
 
ntegrins
 
 are transmembrane 
 
ab
 
 heterodimers that
mediate organization of focal contacts, actin-contain-
ing cytoskeleton, and extracellular matrix (1, 11, 24,
35, 56, 70). Intracellular signals cause changes in integrin
extracellular domains and thereby regulate affinity for ex-
tracellular ligands (22, 30, 33, 35, 38, 59). Regulation of the
interaction of integrins with extracellular ligands allows
control of cell adhesion and migration. Adhesion and mi-
gration, in turn, are important determinants of cell prolif-
eration and differentiation (21, 24, 27, 34, 35, 39). Integrins
are involved in a number of pathological processes (1, 30,
35, 56, 64). Therefore, a detailed understanding is needed
of the complex “inside-out” and “outside-in” signal trans-
duction pathways underlying and provoked by the associa-
tion of integrins with extracellular ligands and intracellular
effector molecules and how these pathways control cellu-
lar behavior.
Three regions of the A splice form of 
 
b
 
1 subunit (
 
b
 
1A)
cytoplasmic domains have been implicated in the function
of 
 
b
 
1A integrins (see Fig. 1). The Asp of the membrane-
proximal sequence KLLXXXXD likely forms a salt bridge
with a conserved Arg of the 
 
a
 
 subunit, thus stabilizing a
default inactive conformation (32). The other regions are
comprised of two NPXY motifs (54). These motifs are
found in the cytoplasmic domains of 
 
b
 
1A and 
 
b
 
1D, 
 
b
 
2, 
 
b
 
3,
 
b
 
5, 
 
b
 
6, and 
 
b
 
7 (see Fig. 1) (25, 49). In all except 
 
b
 
5, the
motifs are separated by an intervening sequence of eight
residues. Substitution of a Pro for a Ser in the intervening
sequence of 
 
b
 
3 is associated with Glanzmann thrombas-
thenia, a bleeding disorder caused by abnormal function of
platelet 
 
a
 
IIb
 
b
 
3 (16, 17). Mutagenesis of the Asn or Pro
residues of the NPXY motifs results in 
 
b
 
 subunits that do
not localize to focal contacts (19, 54). Such changes likely
alter the tight 
 
b
 
-turn predicted for such sequences (3, 28).
When the cDNA for 
 
b
 
1A was first sequenced, the tyrosine
residues of the NPXY motifs were identified as potential
sites of phosphorylation (62). Subsequent studies demon-
strated tyrosine phosphorylation of 
 
b
 
1 in transformed cells
and of 
 
b
 
3 in activated and aggregated platelets and in
 
a
 
v
 
b
 
3-expressing K562 cells (8, 9, 31, 40, 63). Tyrosine
phosphorylated 
 
b
 
1 of 
 
src-
 
transformed cells, detected by
anti-phosphopeptide antibodies, localizes to podosomes
rather than focal contacts (37). Transfected 
 
b
 
1As with one
or both Tyr mutated to Glu, Ala, or Ser localize less well
than wild-type 
 
b
 
1A to focal contacts (19, 54). Transfected
 
b
 
lA with conservative mutations of Tyr to Phe, which can-
not be phosphorylated, localizes normally to focal contacts
(19, 29, 48, 54, 65). 
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We have studied the effects of the Tyr to Phe substitu-
tions in the NPXY motifs on cell behavior. Mutated 
 
b
 
1A
was expressed in mouse GD25 cells, which lack 
 
b
 
1 integrin
heterodimers because of targeted knockout of the 
 
b
 
1 gene
(23, 67). The Tyr to Phe mutations resulted in 
 
b
 
1As that
were active in GD25 cells as assessed by antibody binding
and fibronectin matrix assembly assays. However, the Tyr
to Phe mutations were associated with loss of ability of
cells to undergo directed migration. 
 
Materials and Methods
 
Mutation of 
 
b
 
1A
 
Mutant 
 
b
 
1A constructs were generated from pBS
 
b
 
1A encoding full-
length mouse 
 
b
 
1A integrin subunit (67). The 
 
b
 
1A was cloned into
pGEM7Zf by the unique XbaI and Acc65I restriction sites. Mutants were
generated by oligonucleotide-primed DNA synthesis using the U.S.E. mu-
tagenesis kit (Pharmacia Biotech Sevrage, Uppsala, Sweden). Regions
spanning the Pm1I and Acc65I sites were analyzed by DNA sequence
analysis. Mutagenized PmlI–Acc65I fragments were isolated and ligated
into PmlI–Acc65I-digested pBS
 
b
 
1A to generate cDNAs encoding full-
length 
 
b
 
1A polypeptides containing the individual point mutations in the
cytoplasmic tail. The plasmid was linearized with XbaI and transfected
into 
 
b
 
1-deficient GD25 cells by electroporation. After 72 h, selection with
5 
 
m
 
g/ml puromycin was started. Surviving clones were isolated and ex-
panded. Clones stably expressing 
 
b
 
1A were identified for each mutation.
Clones were monitored for expression of 
 
b
 
1A by flow cytometry. If neces-
sary, the population of higher expressing cells was selected by fluores-
cence detected cell sorting. 
 
Flow Cytometry
 
Cells were harvested and suspended in PBS containing 3% (wt/vol) BSA.
Approximately 1.0 
 
3 
 
10
 
6
 
 cells were incubated with primary antibody, and
then treated with FITC-conjugated secondary antibody at 4
 
8
 
C. We con-
firmed by titration that the dilutions of antibodies used were saturating
and gave maximal specific signals. Cells (8,000 per sample) were analyzed
in a FACScan
 
®
 
 flow cytometer (Becton and Dickinson Co., Mountain
View, CA). Monoclonal antibodies 9EG7 to mouse 
 
b
 
1 (4, 42), MFR5 to
mouse 
 
a
 
5, H9.2B8 to mouse 
 
a
 
v, and 2C9.G2 to mouse 
 
b
 
3 were all from
PharMingen (San Diego, CA). Antibody MB1.2 to mouse 
 
b
 
1 and GoH3
to 
 
a
 
6 were provided by Dr. B. Chan (University of Western Ontario, On-
tario, Canada) and Dr. A. Sonnenberg (The Netherlands Cancer Institute,
Amsterdam, Netherlands), respectively. Possible upregulation of the
9EG7 epitope by Mn
 
2
 
1
 
 or recombinant adhesive modules III7-10 of fi-
bronectin (41) was assessed by flow cytometry (4).
 
Metabolic Labeling and Immunoprecipitation
 
The cells were given methionine-free DMEM, then 
 
l
 
-[
 
35
 
S]methionine
(100 
 
m
 
Ci/ml medium) (Dupont NEN, Boston, MA) and incubated for var-
ious time periods. After incubation, conditioned media were collected,
and cells were solubilized with nonionic detergent buffer (1% [vol/vol]
Triton X-100, 0.05% [vol/vol] Tween 20, 150 mM NaCl, 2 mM PMSF, 5
 
m
 
g/ml leupeptin, 0.1 
 
m
 
g/ml pepstatin A, 0.4 mM pefabloc SC, and 20 mM
Tris-HCl, pH 7.4). Extracellular matrix proteins were immunoprecipitated
with rabbit antibodies from metabolically labeled, conditioned media as
previously described (58). 
 
b
 
1A integrins were immunoprecipitated from
cellular lysates with MB1.2 or 9EG7 by an established protocol (60). The
amounts of antibodies used were sufficient to precipitate all of the target
antigen.
 
Cell Adhesion Assay
 
Cell adhesion assays were performed as previously described (15). Vit-
ronectin (7), fibronectin (43), or laminin-1 (Sigma Chemical Co., St.
Louis, MO) were coated at 2–10 
 
m
 
g/ml onto wells of a 96-well plate, and
the wells were blocked with 2% BSA in PBS containing Ca
 
2
 
1
 
 and Mg
 
2
 
1
 
.
The cells were then allowed to attach to wells for 60 min. After adhesion,
nonadhered cells were removed by washing, and adhered cells were quan-
tified by colorimetric detection at 595 nm after staining with 1% bromphe-
nol blue. 
 
Binding Assays
 
Binding of iodinated or FITC-labeled human plasma fibronectin or the
70-kD NH
 
2
 
-terminal fragment were assayed as described (43, 72). 
 
Immunofluorescence
 
Immunofluorescence studies were performed as described previously
(57). Cells were seeded in serum-containing medium and grown on glass
coverslips for 3 d. Alternatively, cells were seeded onto glass coverslips
coated with vitronectin, fibronectin, or laminin-1 and incubated in DME
containing 0.2% BSA for 4 h at 37
 
8
 
C. For double staining of fibronectin
and 
 
b
 
1 integrin, cells were incubated with FITC-labeled fibronectin in the
presence of 1-oleoyl-lysophosphatidic acid (LPA)
 
1
 
 (Avanti Polar Lipids,
Alabaster, AL) for an additional 1 h at 37
 
8
 
C. Cells were then fixed with
3.5% (wt/vol) paraformaldehyde in phosphate buffer, pH 7.4. Before
staining of intracellular antigens, the cells were permeabilized with 0.2%
Triton X-100 in TBS. After incubation with 3% BSA in TBS to block non-
specific protein binding, the fixed cells were incubated with rabbit antisera
to FITC or fibronectin, and/or monoclonal antibody to paxillin, vinculin,
or 
 
b
 
1, and then treated with FITC anti–mouse IgG, FITC anti–rabbit IgG,
lissamine rhodamine B sulfonyl chloride (LRSC)-labeled anti–rat IgG, or
rhodamine-conjugated phalloidin (Molecular Probes, Inc., Eugene, OR).
Monoclonal antibodies against human vinculin (clone hVIN-1) and chick
paxillin were from Sigma Chemical Co. and Transduction Laboratories
(Lexington, KY), respectively. 
 
b
 
1 integrin was identified with antibody
MB1.2. FITC- or LRSC-conjugated, affinity-purified secondary antibod-
ies were from Jackson ImmunoResearch Labs. Inc. (West Grove, PA).
Controls were done to insure the species specificity of the secondary anti-
bodies. Photographs were taken with an Olympus BX-60 epifluorescence
microscope using additional emission filters that allowed the FITC and
LRSC or rhodamine fluorochromes to be visualized individually or simul-
taneously (Chroma Technology, Brattleboro, VT).
 
Cell Migration
 
Cell migration assays were performed in modified Boyden chambers con-
taining Nucleopore polycarbonate membranes (5-
 
m
 
m pore size; Costar
Corp., Cambridge, MA). The filters were soaked overnight in a 10 
 
m
 
g/ml
solution of vitronectin, fibronectin, or laminin-1 or 100 
 
m
 
g/ml gelatin,
briefly rinsed with PBS containing 0.2% BSA, air dried, and then placed
in the chamber. EGF or PDGF at concentrations of 3–100 ng/ml in DME
containing 0.2% BSA was added to the lower compartment of the cham-
bers. Cells suspended in DME containing 0.2% BSA were introduced into
the upper compartment of the chamber. The chambers were then incu-
bated for 6 h at 37
 
8
 
C. The filters were fixed and stained, and the cells that
had migrated to the lower surface were counted at 400
 
3
 
 magnification.
Two areas from each of two cells were counted. Values are the mean 
 
6
 
SD of cells per 0.16-mm
 
2
 
 field. EGF and PDGF were from Upstate Bio-
technology (Lake Placid, NY) and R&D Systems, Inc. (Minneapolis,
MN), respectively. 
 
Cell Motility
 
The cell motility assay was adapted from an established method (50). Vit-
ronectin, fibronectin or laminin-1, 10 
 
m
 
g/ml, was coated onto wells of a 96-well
plate, and the wells were blocked with 2% BSA in PBS containing Ca
 
2
 
1
 
and Mg
 
2
 
1
 
. Yellow polystyrene monodispersed particles (1.0-
 
m
 
m-diam
polybeads; Polysciences, Inc., Warrington, PA) were suspended with
DME, sonicated three times, and then added to wells. The plates were
centrifuged at 1,400 rpm for 25 min and incubated overnight at 37
 
8
 
C. Cells
(500 cells/well) suspended in DME containing 0.2% BSA in the absence
or presence of motility factors, PDGF or EGF, 3–100 ng/ml, were intro-
duced into wells and incubated for 16 h at 37
 
8
 
C. After incubation, the con-
tents of the wells were fixed with 10% (vol/vol) glutaraldehyde, wells were
washed, and clearing of beads by motile cells was assessed by phase mi-
croscopy. 
 
Presentation of Results
 
Experiments were done on at least three separate occasions over an 8-mo
period on clones of cells selected to give maximal expression in the case of
the P781A, T788P, P793A, or P781,793A mutants or expression similar to
 
1. 
 
Abbreviations used in this paper
 
: FAK, focal adhesion kinase; LPA,
lysophosphatidic acid; LRSC, lissamine rhodamine B sulfonyl chloride. 
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GD25-
 
b
 
1A cells in the case of the D759A, Y783F, Y795F, or Y783,795F
mutants. The cell migration assays and microscopic analysis of microfila-
ment bundles and focal contacts were repeated on independently derived
clones of D759A and Y783,795F cells. The experiments and photomicro-
graphs shown were chosen as representative of differences constantly ob-
served among cells expressing the different 
 
b
 
1As. 
 
Results
 
We characterized the effects of Tyr to Phe mutations in
the NPXY motifs of 
 
b
 
1A in mouse GD25 cells, which lack
expression of 
 
b
 
1 integrin heterodimers because of tar-
geted knockout of the 
 
b
 
1 gene (23, 67). We also created
point mutations that would be expected, on the basis of
previous studies described in the Introduction, to enhance
or interfere with integrin activity (Fig. 1). 
 
Analysis of Integrins and Cell Attachment
 
Expression of cell surface 
 
b
 
1A and associated a5 and a6
subunits was analyzed by flow cytometry (Fig. 2). Trans-
fection of b1A mutants resulted in appearance of cell sur-
face a5 and upregulation of cell surface a6, as previously
reported for GD25-b1A cells expressing wild-type b1A
(23, 67). Binding of monoclonal antibody 9EG7, which
recognizes an extracellular epitope of b1 that can be up-
regulated by Mn21 or ligand, was compared with the bind-
ing of a second anti-b1 monoclonal antibody, MB1.2, as an
index for conformationally active integrins. For GD25-
b1A cells and cells expressing D759A, Y783F, Y795F, or
double Y783,795F mutant b1A, fluorescence resulting from
binding of 9EG7 was 80–100% of that due to MB1.2 bind-
ing. Attempts to upregulate the 9EG7 epitope further with
Mn21 or recombinant adhesive modules III-7-10 of fibronec-
tin failed (not shown). For each of the four mutants, cell
surface b1A was expressed at a level comparable to that of
GD25-b1A cells (67) in at least 6 of the z50 clones tested.
Metabolic labeling and immunoprecipitation analysis con-
firmed that the production level of the D759A or Y783,795F
Figure 1. Deduced amino acid sequence (in single letter code) of
the intracellular domain of murine b1A and comparable domains
of b1D, b2, b3, b5, b6, and b7. The sequences are aligned with
lysine (K) at position 752 of mature b1A. The residues mutated
in b1A and homologous residues in other b subunits are shown in
bold. The mutations are depicted above the b1A sequence.
Figure 2. Expression of b1A and associated a5
and a6 subunits in b1-deficient GD25, wild-type,
and mutant b1A cells by flow cytometry. Control,
no primary antibody; b1(9EG7), and b1(MB1.2),
antibodies to b1; a5(MFR5), antibody to a5;
a6(GoH3), antibody to a6; GD25, b1-deficient
cells; b1GD25, GD25 cells expressing wild-type
b1A; other cells are designated by mutation(s). The Journal of Cell Biology, Volume 141, 1998 530
mutant b1A was not different from production of wild-
type b1A in the GD25-b1A cells (not shown). 
Binding of 9EG7 to cells expressing P781A, T788P,
P793A, or double P781,793A mutant b1As, in contrast,
was ,50% of MB1.2 binding (not shown). In addition, we
were unable to find cells expressing P781A, T788P, P793A
or double P781,793A mutant b1As that bound MB1.2 at
.30% of the expression level on GD25-b1A cells despite
testing  z50 (P781A and P793A) or z100 (T788P and
P781,793A) clones. The flow cytometry results, therefore,
indicate that wild-type b1A and the D759A, Y783F, Y795F,
and double Y783,795F mutant b1As are all expressed in
an active state by GD25 cells. In contrast, the P781A,
T788P, P793A, and double P781,793A mutant b1As are
expressed less well and in a less active state. 
Transfection and selection of D759A or double Y783,795F
mutant b1A resulted in variable downregulation of cell
surface av and b3 when compared with the parent GD25
cells (not shown). Similar results were obtained previously
using surface iodination of GD25 and GD25 b1A cells (67).
Cell adhesion studies were carried out to characterize
further the activity of the mutant integrins. Cells trans-
fected with any of the set of b1As that resulted in higher
ratios of 9EG7/MB1.2 binding adhered vigorously to lami-
nin-1, whereas untransfected GD25 cells or GD25 cells
transfected with the P781A, T788P, P793A, or P781,793A
mutant attached and spread poorly on cell culture plastic
coated with laminin-1 (Fig. 3). Adherence to laminin-1
was blocked by antibody GoH3 to a6b1 (not shown).
GD25 cells or each of the transfectants attached and
spread on vitronectin or fibronectin (Fig. 3), consistent
with previous studies showing that adhesion of GD25 cells
to fibronectin can be mediated by either the avb3 vit-
ronectin receptor or the a5b1 fibronectin receptor (23,
67). These results indicate that substitution of Ala for Pro
in the NPXY motifs or the thrombasthenia-like Thr-to-Pro
substitution in the sequence between the two motifs re-
sults in poorly expressed integrins with little or no a6b1-
mediated cell adhesive activity for laminin-1. Integrins
Figure 3. Attachment of wild-type and mutant b1A cells on vit-
ronectin, fibronectin, and laminin-1. Bars represent the mean of
attachment activity quantified by spectrophotometric analysis at
OD 5 595 nm after staining of adherent cells with bromphenol
blue. Error bars represent 6SD of quadruplicate experiments.
Absorbance resulting from nonspecific cell adhesion as measured
on BSA-coated wells was z0.05, and has been subtracted. GD25,
b1-deficient cells; b1GD25, GD25 cells expressing wild-type
b1A; other cells are designated by mutation(s). 
Figure 4. Immunofluores-
cence of fibronectin matrix
after 3 d of culture in serum-
containing medium. GD25,
b1-deficient cells; b1GD25,
GD25 cells expressing wild-
type  b1A; other cells are des-
ignated by mutation(s). Bar,
60 mm.Sakai et al. Tyrosine Residues of b1A Integrin 531
formed by b1A carrying the D759A mutations or substitu-
tion of Phe for Tyr in the NPXY motifs, in contrast, were
at least as active as those formed by wild-type b1A. 
Fibronectin Matrix Assembly by Cells Expressing 
Mutant b1A
Fibronectin assembly is enhanced by experimental manip-
ulations that activate b1 or b3 integrins, including activat-
ing antibodies, truncation of the a subunit cytoplasmic do-
main, and mutation of the membrane-proximal Asp to
disrupt the interaction between a and b cytoplasmic do-
mains (32, 69). To learn whether expression of b1As with
Tyr to Phe mutations in the NPXY motifs also results in
hyperactive integrins, we studied assembly of fibronectin
by monolayers of transfected cells. After 3 d in 10% FBS,
fibronectin was deposited in a fibrillar pattern around
most cells expressing wild-type b1A or D759A or double
Y783,795F mutant b1A (Fig. 4). Fibronectin deposition
was more patchy in cultures of GD25 cells in that foci of
cells had copious matrix whereas nearby cells had none
(Fig. 4). No differences were found between GD25 cells
and GD25 cells expressing wild-type b1A or among cells
expressing wild-type or mutant b1As in the secretion of fi-
bronectin, or of laminin-1 or tenascin-C, when media of
Figure 5. Assembly of exog-
enous fibronectin in short-
term assay. Assembly of
FITC–fibronectin during a 1-h
period began 4 h after seeding
of cells on surfaces coated
with vitronectin or laminin-1.
The cells used for analysis are
indicated in each figure. Bar,
60 mm. 
Figure 6. Binding of the 70-kD NH2-terminal fragment of fi-
bronectin to cells seeded on surfaces coated with vitronectin, fi-
bronectin, or laminin-1. Symbols represent the mean of specific
binding. Bars represent mean 6 SD of triplicate experiments
with duplicate determinations in each experiment (n 5 6). GD25,
b1-deficient cells; b1GD25, GD25 cells expressing wild-type
b1A; other cells are designated by mutation(s). *, b1-deficient
GD25 cells could not be studied on laminin-1 coating because too
few cells adhered (see Fig. 3).The Journal of Cell Biology, Volume 141, 1998 532
cells incubated with [35S]methionine were analyzed by im-
munoprecipitation (not shown). 
We also analyzed fibronectin matrix deposition in short-
term experiments. Fig. 5 shows fluorescence due to deposi-
tion over a 1-h period of FITC-labeled plasma fibronectin
added to cells in plates coated with vitronectin or laminin-1.
The vitronectin coating supported extensive network of
assembled fibronectin formed around cells expressing
wild-type  b1A or D759A, Y783F, Y795F, or Y783,795F
mutant b1A (Fig. 5). In contrast, untransfected GD25
(Fig. 5) cells or cells expressing inactive T788P or
P781,793A mutant b1A (not shown) did not assemble fi-
bronectin over this time period when cultured on vitronec-
tin. Thus, assembly of a matrix by GD25 cells cultured
short-term on vitronectin requires active b1 integrins. Fi-
bronectin deposition around cells expressing b1A or the
D759A mutation or the Phe for Tyr substitutions, whether
cultured on vitronectin or laminin-1, consistently stained
at least as intensely as cells expressing wild-type b1A (Fig. 5). 
The qualitative fluorescence microscopic observations in
Fig. 5 were buttressed by assays of binding of 125I-labeled,
70-kD NH2-terminal fragment of fibronectin (Fig. 6). This
fragment is a suitable probe to quantify the ability of cells
to assemble fibronectin, inasmuch as the fragment and in-
tact fibronectin bind to cell layers with the same affinities,
cross-compete for binding, and can be cross-linked to the
same large apparent molecular mass target in cell layers
(46, 71). Cells expressing D759A or Y783,795F mutant
b1A bound 1.5- to 2.5-fold more 70-kD fragment than
cells expressing wild-type b1A. Binding to cells expressing
b1A with the single Tyr mutation was intermediate be-
tween binding to cells expressing b1A with the double Tyr
mutations and cells expressing wild-type b1A. Increased
binding was found regardless of whether cells were cul-
tured on vitronectin, fibronectin, or laminin-1 and was en-
hanced by LPA, which causes a coordinated change in cell
shape, and upregulation of binding of fibronectin or the
70-kD fragment (45, 72).
Cellular Localization of b1A in Relationship to 
Assembled Fibronectin
Activated integrins are required in the process of fibronec-
tin matrix assembly (69). We therefore analyzed cellular
localization of wild-type b1A or D759A or Y783,795F
mutant b1A in relationship to assembled fibronectin by
fluorescence microscopy of cells cultured on vitronectin,
fibronectin, or laminin-1 and incubated with FITC–fibronec-
tin before fixation and staining for b1 (Fig. 7). These three
cell types in general behaved in the same manner on a
given substrate. However, they showed different subcellu-
lar localization of b1A that depended upon the different
substratum. In cells adherent to vitronectin, b1A did not
localize to focal contacts but rather to assembled fibronec-
tin. In cells adherent to fibronectin, some b1A localized to
focal contacts of cells, and some was associated with as-
sembled fibronectin, especially around cells expressing wild-
type b1A and, to a lesser extent, around cells expressing
D759A or Y783,795F mutant b1A. b1A localized to focal
contacts of all three cell types when cultured on laminin-1.
These focal contacts were linear and often associated with
FITC–fibronectin. 
Cell Motility and Migration of Cells Expressing
Wild-Type b1A or Mutant b1As
Motility of GD25 cells and the various transfectants was
assessed by an assay in which moving cells displace poly-
styrene beads layered onto surfaces coated with vitronec-
Figure 7. Double fluores-
cence of b1 integrin (red)
and FITC-labeled fibronectin
(green). Cells were incubated
for 4 h on a fibronectin-, lami-
nin-, or vitronectin-coated sub-
stratum  and additional 1 h
with FITC–fibronectin. After
fixation with paraformalde-
hyde,  staining for b1 integrin
was performed using b1 anti-
body MB1.2 and LRSC-
labeled anti–rat IgG. Sam-
ples were viewed with an
emission filter that allowed
visualization of both fluoro-
chromes and photographed
focusing on the interface of
cells and substrate. GD25, b1-
deficient cells; b1GD25, GD25
cells expressing wild-type b1A;
other cells are designated by
mutation(s). Bar, 25 mm. Sakai et al. Tyrosine Residues of b1A Integrin 533
tin, fibronectin, or laminin-1 (Fig. 8). GD25 cells cultured
in the presence of PDGF (Fig. 8) or EGF (not shown)
demonstrated little motility. GD25 cells expressing wild-
type b1A or various mutants of b1A were not motile in
the absence of PDGF or EGF (not shown). Addition of
PDGF (Fig. 8) or EGF (not shown) caused greater motil-
ity of b1A-expressing cells, that is, a greater area around
cells was cleared of beads. The areas cleared by cells ex-
pressing wild-type b1A or the D759A mutant tended to be
asymmetrical and irregular whereas areas cleared by cells
expressing the Phe for Tyr substitutions, especially Y795F,
were rounder. These patterns were found regardless of
which adhesive protein (vitronectin, fibronectin, or lami-
nin-1) was present on the surface and which motility agent
(EGF or PDGF) was present in the medium.
Transwell migration assays were performed in blind-
well chambers fitted with filters coated with vitronectin, fi-
bronectin, or laminin-1. In the absence of EGF or PDGF,
4- to 10-fold more cells moved across filters coated with fi-
bronectin (Fig. 9) than filters coated with gelatin (,10
Figure 8. Cell motility as as-
sessed by clearing of beads
layered on vitronectin-, fibro-
nectin-, or laminin-1–coated
surfaces. Cells were added in
the presence of PDGF, 10 ng/
ml. Wells were fixed 16 hours
after seeding and photo-
graphed by phase micros-
copy. Cells, which were cov-
ered with beads, appear as
dark specks in cleared-out
areas.  GD25,  b1-deficient
cells; b1GD25, GD25 cells
expressing wild-type b1A;
other cells are designated by
mutation(s). Bar, 240 mm.The Journal of Cell Biology, Volume 141, 1998 534
cells/0.16 mm2; not shown). This increase is presumed to
represent a haptotactic response. The haptotactic re-
sponses to vitronectin were both less in magnitude and less
variable than the haptotactic response to fibronectin,
whereas the haptotactic responses to laminin-1 were equally
variable (Fig. 9). GD25 and Y783,795F cells did not dem-
onstrate haptotaxis through laminin-1–coated filters. 
In response to EGF or PDGF, GD25 cells expressing
wild-type b1A or the D759A mutant migrated two- to
fourfold more than GD25 cells lacking b1A (Fig. 9). These
results indicate that migration is enhanced by b1A inte-
grins interacting with the adhesive substrates coating the
filter, probably avb1A with vitronectin, a6b1A with lami-
nin-1, and a5b1A with fibronectin. In response to EGF,
D759A cells and cells expressing wild-type b1A migrated
equivalently. In response to PDGF, D759A cells migrated
better than cells expressing wild-type b1A. Y783,785F
cells, in contrast, migrated much less than cells expressing
wild-type b1A and no more than cells lacking b1A. Y783F
and Y795F cells had migratory behavior that was interme-
diate between Y783,795F cells and cells expressing wild-
type b1A. In all experiments, however, migration of cells
expressing the Y783F mutation was less than migration of
cells expressing the Y795F mutation. Differences in migra-
tion ability among cells expressing various mutant b1As
were found over a 30-fold range of concentrations (3–100
ng/ml) of both of the chemotactic agents (not shown). 
In the bead clearing assay, Y795F cells were most active,
and the Y783,795F cells were as active as cells expressing
wild-type b1A (Fig. 8). The discrepancy in behavior be-
tween the bead clearing assay and the chemotaxis assay
shown in Fig. 9 was investigated by checkerboard analysis
in which different concentrations of chemotactic agent are
added to the upper and lower chamber of the apparatus
(Table I). Such an analysis differentiates directed migra-
tion across the filter in response to a gradient of chemotac-
tic agent (chemotaxis) from increased random motility be-
cause of the presence of the chemotactic agent per se
(chemokinesis). Cells expressing wild-type b1A and the
D759A mutant responded to a gradient of PDGF by
chemotaxis but demonstrated only a low and variable
chemokinetic response to increasing concentrations of
PDGF in both chambers. The chemokinetic responses of
wild-type and D759A cells were more than twofold less
than the chemotactic responses. Migration of Y795F cells,
in contrast, was greater when PDGF was present in both
chambers than when there was a gradient of PDGF, indi-
cating that the chemokinetic response was the main effect.
Migration of Y783,795F and Y783F cells was low in magni-
tude and variable between fibronectin- and vitronectin-
coated filters, making it difficult to classify the migration
as chemotaxis or chemokinesis. 
Focal Contact Formation and Actin Cytoskeleton 
Organization in Cells Expressing Wild-Type b1A or 
Mutant b1As
Cells expressing wild-type b1A and the D759A and
Y783,795F mutants were analyzed for focal contacts with
antipaxillin (Fig. 10 A) and antivinculin (Fig. 10 B) and for
F-actin–containing cytoskeleton with rhodamine phalloi-
din (Fig. 10 B). As assessed by paxillin or vinculin staining,
focal contacts formed by D759A cells on fibronectin were
larger, coarser, and more numerous than focal contacts
formed by cells expressing wild-type b1A. More numerous
focal contacts were also formed by Y783,795F cells on fi-
bronectin. Compared with the focal contacts formed by
D759A cells, focal contacts of Y783,795F cells were finer
and more uniform in size. The differences in the patterns
of paxillin and vinculin staining among the three cell types
on fibronectin were similar to the difference in staining
patterns of b1A (Fig. 7; more obvious in studies not shown
in which only single fluorescence for b1 was done). The
difference between vinculin-containing focal contacts of
D759A and Y783,795F cells was also found when the cells
were cultured on vitronectin-coated surfaces (Fig. 10 B)
even though b1A could not be demonstrated in focal con-
tacts (see Fig. 7). On the vitronectin-coated substratum,
vinculin-staining focal contacts of cells expressing wild-
type  b1A were coarser and more heterogenous than wild-
type cells on the other substrates. On a laminin-1–coated
substratum, more vinculin-staining focal contacts were
present in cells expressing wild-type b1A or the D759A
mutant than in Y783,795F cells. 
Figure 9. Cell migration through vitronectin-, fibronectin-, or
laminin-1–coated filters in response to EGF or PDGF. EGF (100
ng/ml) or PDGF (10 ng/ml), was in the lower chamber. Each bar
represents the mean of cell number per 0.16-mm2 field. Error bars
indicate 6 SD of quadruplicate determinations. GD25, b1-defi-
cient cells; b1GD25, GD25 cells expressing wild-type b1A; other
cells are designated by mutation(s). Sakai et al. Tyrosine Residues of b1A Integrin 535
Cells expressing wild-type b1A or the D759A mutant,
when stained with rhodamine phalloidin, contained thick
cables that ran through most of the length of the cells (Fig.
10  B). These cables terminated in the coarse vinculin-
staining focal contacts. The F-actin network of Y783,795F
cells was more peripheral than in cells expressing wild-
type b1A or the D759A mutant and terminated in the fine
vinculin-staining focal contacts. The differences in F-actin
distribution were noted on all three substrata. For each of
the transfected cell types, however, the F-actin network
was less when cells were on vitronectin. Each of the trans-
fected cell types had a better developed F-actin network
than nontransfected GD25 cells on vitronectin or fibronec-
tin (Fig. 10 B). 
Discussion
We studied eight cytoplasmic mutant of b1A—four active
(D759A, Y783F, Y795F, and Y783,795F) and four inactive
(P781A, T788P, P793A, and P781,793A) as judged by re-
activity with the 9EG7 anti-b1 antibody, adhesion to lami-
nin-1, and ability to support fibronectin assembly. (Re-
cently, it was reported that human foreskin fibroblasts do
not assemble fibronectin when cultured on vitronectin
[18]. In our hands, human foreskin fibroblasts do assemble
fibronectin when cultured on vitronectin, and the inability
to assemble fibronectin when cultured on vitronectin is a
specific property of cells deficient in active b1 integrin
[Zhang, Q., T. Sakai, R. Fässler, J. Nowlen, and D.F.
Mosher, manuscript in preparation]). The active b1As
were associated with distinctive cellular phenotypes.
D759A cells had thick F-actin–containing microfilaments
that terminated in coarse vinculin-containing focal con-
tacts. Y783,795F cells had thinner and more peripheral
F-actin–containing microfilaments that terminated in fine
focal contacts. The cytoskeletal phenotypes were found
when cells were on vitronectin-coated substrates, in which
b1A was associated with assembling fibronectin, as well as
on fibronectin- or laminin-1–coated substrates, in which b1A
was associated both with focal contacts and assembling fi-
bronectin. Motility phenotypes were associated with the
cytoskeletal phenotypes. D759A cells were as active as
cells expressing wild-type b1A in chemotaxis assays whereas
Y783,795F cells were no more active than cells lacking
b1A and Y795F demonstrated a strong chemokinetic re-
sponse.
Cell migration is a complex process that involves lamel-
lipodial extension, generation of intracellular force, inte-
Table I. Checkerboard Analysis of PDGF-induced Cell Migration of b1-deficient GD25, and GD25 Wild-Type or Mutant 
b1A
Vitronectin Fibronectin
Concentration of PDGF
Upper compartment
Concentration of PDGF
Upper compartment
0 10 30 0 10 30
GD25 GD25
Lower compartment ng/ml Lower compartment ng/ml
0 34 6 4 37 6 4 35 6 2 0 27 6 2 31 6 2 34 6 4
10 87 6 10 88 6 8 90 6 5 10 90 6 2 60 6 3 56 6 3
30 105 6 6 104 6 5 114 6 3 30 72 6 6 67 6 4 75 6 5
b1GD25 b1GD25
Lower compartment Lower compartment
0 37 6 6 48 6 3 55 6 7 0 84 6 4 50 6 6 32 6 2
10 155 6 12 76 6 12 56 6 3 10 129 6 7 57 6 3 36 6 6
30 198 6 10 91 6 9 63 6 6 30 105 6 3 78 6 4 58 6 5
D759A D759A
Lower compartment Lower compartment
0 36 6 2 43 6 3 52 6 3 0 73 6 4 53 6 3 37 6 5
10 206 6 4 127 6 13 96 6 5 10 172 6 17 109 6 12 83 6 8
30 221 6 13 144 6 7 104 6 4 30 242 6 14 165 6 8 103 6 6
Y783, 795F Y783, 795F
Lower compartment Lower compartment
0 25 6 2 28 6 4 18 6 2 0 31 6 2 26 6 2 31 6 2
10 51 6 2 32 6 2 25 6 2 10 59 6 3 48 6 2 46 6 5
30 44 6 3 34 6 4 37 6 3 30 56 6 3 50 6 3 57 6 3
Y783F Y783F
Lower compartment Lower compartment
0 25 6 2 29 6 3 31 6 5 0 44 6 3 41 6 2 38 6 4
10 87 6 6 43 6 4 35 6 3 10 70 6 2 60 6 3 52 6 5
30 61 6 4 42 6 5 32 6 3 30 62 6 6 61 6 3 69 6 3
Y795F Y795F
Lower compartment Lower compartment
0 30 6 3 54 6 4 62 6 4 0 58 6 8 84 6 8 92 6 4
10 117 6 8 123 6 5 114 6 4 10 102 6 3 122 6 7 130 6 9
30 120 6 3 125 6 8 129 6 16 30 112 6 7 125 6 5 144 6 12
Cell migration assays through fibronectin- or vitronectin-coated filters were performed as described in Materials and Methods except that variable concentrations of PDGF were
added to the upper as well as the lower chamber. Results are expressed as the mean 6 SD (n 5 4) of cells that had migrated to the lower surface of the filter. GD25, b1-deficient
cells; b1GD25, GD25 cells expressing wild-type b1A; other cells are designated by mutation(s).The Journal of Cell Biology, Volume 141, 1998 536
grin clustering in focal contacts, integrin avidity, and inte-
grin signaling (34, 39, 51, 61). Focal contacts are enriched
in a large number of kinases, at least one phosphatase, and
various adapter and connector proteins (11, 22, 27, 38, 44,
70). Phe lacks the hydroxyl group that is the acceptor
site for tyrosine phosphorylation. The results suggest,
therefore, that conversion of tyrosines between nonphos-
phorylated and phosphorylated states is critical for move-
ment on adhesive substrates (Fig. 11). Phosphorylated in-
tegrins are hypothesized to initiate a pathway leading to
changes in F-actin–containing cytoskeleton and genera-
tion of the polarity required for directional movement.
NPXY motifs are also hypothesized to regulate cellular lo-
calization of b1A integrins. Cells lacking focal adhesion ty-
rosine kinase (FAK) exhibit reduced motility and in-
creased numbers of focal contacts whereas overexpression
of FAK causes increased motility (14, 36). Enhancement
of tyrosine phosphorylation causes loss of focal contacts
(20, 47). Phosphorylated b1 integrins of src-transformed
fibroblasts do not localize to focal contacts (37). Solubi-
lized phosphorylated integrins from src-transformed fibro-
blasts, in contrast to integrins from normal fibroblasts, fail
to bind to an extracellular ligand, fibronectin, or cytoplas-
mic protein, talin (63). These observations all suggest that
upon phosphorylation of the NPXY motifs by tyrosine ki-
nase(s), the integrin loses its affinity for both extracellular
ligand and cytoplasmic components of the focal contacts
and exits the focal contact. Dephosphorylation of the mo-
tifs by unknown tyrosine phosphatase(s) would allow the
integrin to participate in a new round of ligation and focal
contact formation. The two hypotheses shown in Fig. 11
could be linked in the sense that the cytoskeleton may po-
larize the cycling of integrins. 
For phosphorylated integrins to initiate a pathway lead-
ing to changes in F-actin–containing cytoskeleton, one or
more adaptor molecules specific for the phosphorylated
NPXY motifs would be required. Tyrosine-phosphory-
lated intracellular domains interact with Grb2 and Shc in
the case of b3 (40) and with the P85 of phosphoinositide-3
kinase (PI-3) kinase in the case of b1A (37). However, the
double Phe for Tyr substitution did not impair the ability
of human b1A transfected into mouse 3T3 cells to signal
via Shc when cross-linked by mouse anti–human b1 anti-
body (66). D759A and Y783,795F cells each had increased
numbers of focal contacts and upregulation of fibronectin
assembly. Increased focal contacts also correlate with in-
creased assembly when cells are treated with LPA (2, 45,
55, 72, 73). The patterns of focal contacts in D759A and
Y783,795F cells, however, were strikingly different. The
different patterns and the divergent behavior of the two
cells in the migration assay suggest that the mutations in-
fluence focal contacts by impinging at different points in
the pathway shown in Fig. 11. The D759A mutation likely
increases the avidity of b1A integrins for extracellular
Figure 10. Visualization of
focal contacts and associated
structures in b1-deficient
GD25, wild-type or mutant
b1A cells. (A) Immunofluo-
rescent detection of paxillin
in focal contacts of cells ex-
pressing wild-type b1A, or
D759A, or Y783,795F mutations. Cells were cultured for 4 h on a fibronectin-coated substratum. (B) Double fluorescence of vinculin
(green) and rhodamine–phallondin (red). Cells were incubated for 4 h on a fibronectin-, laminin-1–, or vitronectin-coated substratum.
GD25, b1-deficient cells; b1GD25, GD25 cells expressing wild-type b1A; other cells are designated by mutation(s). Bar, 25 mm.Sakai et al. Tyrosine Residues of b1A Integrin 537
ligands and the probability that integrins will bind ligand
and enter focal contacts (32). Increased avidity of integrins
for ligands does not slow migration but rather lowers the
density of ligands required for maximum migration (12,
34, 39, 51). The Y783,795F mutations, as above, are hy-
pothesized to cause persistence of ligated b1A integrins in
focal contacts. 
b3 in which the tyrosine homologous to Y783 in b1A
was mutated to phenylalanine failed to induce adhesion
and clot retraction by cells in which b3 integrins are consti-
tutively inactive (9). Our tyrosine mutants of b1A were
constitutively active in GD25 cells. We do not know
whether expression of the mutant b1As in cells in which
the integrins are constitutively inactive would reveal addi-
tional functions for the phosphorylation. Indeed, the argu-
ment that phosphorylation rather than the simple absence
of the hydroxyl group explains the observed phenotype of
transfected GD25 cells is circumstantial. The argument is
based on the fact that b1A can, in principle, be phosphory-
lated as evidenced by studies of transformed cells and pre-
sumes that only a small, undetectable fraction of b1A is
phosphorylated at any one time in untransformed cells. 
Several of the substitutions generated in the present in-
vestigation are found naturally in other b subunits (Fig. 1).
In b1D, the conserved Thr in the sequence between the
NPXY motifs is an Asn, and a Pro is present in the se-
quence. b1D is a muscle-specific integrin found in junc-
tions where there is high tensile strength (5). b1D-transfected
GD25 display retarded spreading, reduced cell migration,
enhanced contractility, and robust ability to assemble fi-
bronectin matrix when compared with b1A-expressing
counterparts (6). Transfected b1D is targeted to focal con-
tacts and is also more strongly associated with detergent-
insoluble cytoskeleton than b1A. These results suggest
that alternative splicing of b1 is a means to strengthen the
cytoskeleton–matrix link where an extremely stable asso-
ciation is required for contraction (6). In b2, Tyr of both
NPXY motifs are replaced by Phe. b2 integrins interact
with counter receptors on other cells, thus localizing lym-
phocytes and leukocytes in inflammatory and immunolog-
ical reactions and facilitating interactions among these
cells (13, 26, 30, 35, 56). These and other (10, 24, 30, 35, 52,
53, 64, 68) natural variations in NPXY sequences in b sub-
units may determine the kinetics with which integrins en-
ter and exit focal contacts and the relative abilities of inte-
grins to mediate cell migration, stable adhesions, endocytosis,
and assembly of extracellular matrix.
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